Laboratory Diagnosis of the Thrombophilic State in Cancer Patients

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Seminars in Thrombosis and Hemostasis

• Publication date

  1999-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-2007-994918PMID 10357084
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet activation.

  2020cited by this paper
• Hemostatic alterations in cancer patients

  2005cited by this paper
• The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia.

  1998cited by this paper
• Prevention of venous thromboembolism.

  1998cited by this paper
• Prognostic impact of an activation of coagulation in lung cancer.

  1998cited by this paper
• Mechanisms of Hypercoagulation in Malignancy and during Chemotherapy

  1998cited by this paper
• Elevated TFPI in malignant disease: relation to cancer type and hypercoagulation

  1998cited by this paper
• Markers of hypercoagulability in cancer patients.

  1997influential reference
• Prevention of Thrombotic Disorders in Cancer Patients Undergoing Chemotherapy

  1997cited by this paper
• Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue.

  1997cited by this paper
• Tumour cell u‐PA as a cause of fibrinolytic bleeding in metastatic disease

  1997cited by this paper
• Coagulation and Fibrinolysis Activation Markers in Prostatic Carcinoma Patients

  1997cited by this paper
• Haemostatic abnormalities in lung cancer: prognostic implications.

  1997cited by this paper
• Prognostic impact of an activation of coagulation in lung cancer.

  1997cited by this paper
• Prognostic significance of plasma D-dimer levels in patients with lung cancer.

  1997cited by this paper
• Blood Coagulation and Thrombosis in Patients with Ovarian Malignancy

  1997cited by this paper
• Hypercoagulability in cancer.

  1996cited by this paper
• Tissue factor in cancer angiogenesis and metastasis

  1996cited by this paper
• Markers of activated coagulation and their usefulness in the clinical laboratory.

  1996cited by this paper
• Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor.

  1995cited by this paper
• Prevention of venous thromboembolism.

  1995cited by this paper
• Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients

  1995cited by this paper
• Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.

  1994cited by this paper
• Guidelines for Clotting Studies in Cancer Patients

  1993cited by this paper
• Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery

  1993cited by this paper
• Coagulation Abnormalities in Malignancy: A Review

  1992influential reference
• Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis.

  1992cited by this paper
• Tissue factor as a tumor procoagulant

  1992cited by this paper
• Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.

  1992cited by this paper
• Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin.

  1992cited by this paper
• Animal Tumor Procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society of Thrombosis and Haemostasis

  1990cited by this paper
• Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial.

  1990cited by this paper
• Fibrinolysis and Cancer

  1990cited by this paper
• High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer.

  1989cited by this paper
• DETECTION OF FACTOR X ACTIVATION IN HUMANS

  1989cited by this paper
• A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.

  1989cited by this paper
• A new procoagulant in acute leukemia.

  1988cited by this paper
• The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.

  1988cited by this paper
• Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188.

  1988cited by this paper
• Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.

  1985cited by this paper
• The Role of Hemostasis and Fibrinolysis in the Metastatic Spread of Cancer

  1984cited by this paper
• Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate: Final Report of VA cooperative study # 75

  1984cited by this paper
• Activation of blood coagulation in cancer: Trousseau's syndrome revisited.

  1983cited by this paper
• A factor X-activating cysteine protease from malignant tissue.

  1981cited by this paper
• Phlegmasia alba dolens.

  year unknowncited by this paper

• Development of an algorithm for identifying paraneoplastic ischemic stroke in association with lung, pancreatic, and colorectal cancer

  2024cites this paper
• Radiotherapy for Esophageal Squamous Cell Carcinoma Concomitant With Hypoproteinemia: a Case Report

  2021cites this paper
• Analysis of haemostasis biomarkers in patients with advanced stage lung cancer during hypofractionated radiotherapy treatment

  2018cites this paper
• Appraisal of Basic-Hemostatic Markers in Lung Cancer Patients During Follow-Up Care After Radiotherapy Treatment

  2018cites this paper
• Understanding and treating solid tumor–related disseminated intravascular coagulation in the “era” of targeted cancer therapies

  2017cites this paper
• Clinical significance of coagulation factors in operable colorectal cancer

  2017cites this paper
• Neuroimaging of Cerebrovascular Complications in Cancer Patients

  2016cites this paper
• A Rare Occurrence of Simultaneous Venous and Arterial Thromboembolic Events – Lower Limb Deep Venous Thrombosis and Pulmonary Thromboembolism as Initial Presentation in Acute Promyelocytic Leukemia

  2016cites this paper
• D-Dimer and Carcinoembryonic Antigen Levels: Useful Indicators for Predicting the Tumor Stage and Postoperative Survival

  2016cites this paper
• Clotting Factors and Antithrombotic Factors in Selected Epithelial Malignancies

  2015cites this paper
• The prognostic value of D‐dimer in lung cancer

  2015cites this paper
• Clotting Factors and Antithrombotic Factors in Selected

  2015cites this paper
• Thromboprophylaxis in Cancer Patients

  2014cites this paper
• The Equine PeptideAtlas: A resource for developing proteomics‐based veterinary research

  2014cites this paper
• Relationships of Coagulation Factor XIII Activity with Cell-Type and Stage of Non-Small Cell Lung Cancer

  2013cites this paper
• Assessment of Protein C, Protein S, and prothrombin levels in gastrointestinal carcinoma with and without metastasis

  2013cites this paper
• Prospective study on Clotting Factors in selected non-hematologicalmalignancies.

  2013cites this paper
• Prognostic value of the D‐dimer test in oesophageal cancer during the perioperative period

  2013cites this paper
• F2RL3 Methylation as a Biomarker of Current and Lifetime Smoking Exposures

  2013cites this paper
• Mit klinischem Gespür die Gefahr für Tumorpatienten einschätzen

  2013cites this paper
• Plasma D-Dimer Level as a Mortality Predictor in Patients with Advanced or Recurrent Colorectal Cancer

  2012cites this paper
• Haemostatic alterations in a group of canine cancer patients are associated with cancer type and disease progression

  2012cites this paper
• Diagnosis of Chronic Disseminated Intravascular Coagulation in 72 Cancer Patients According to the International Society on Thrombosis and Hemostasis Score System

  2012cites this paper
• [Venous thromboembolism in cancer].

  2012cites this paper
• Venous Thromboembolism in Cancer Patients Undergoing Major Abdominal Surgery: Prevention and Management

  2012cites this paper
• Mit klinischem Gespür die Gefahr einschätzen

  2012cites this paper
• Is coagulation factor VIII a useful marker for colorectal carcinoma?

  2012cites this paper
• Zellbiologische Effekte aktivierter Gerinnungsfaktoren auf Tumorzellen

  2011cites this paper
• Prognostic Significance of Plasma D-Dimer Levels in Patients with Lung Cancer

  2010cites this paper
• Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer

  2010cites this paper
• Thromboembolic complications in malignant haematological disorders.

  2010cites this paper
• The effects of low-molecular-weight heparin at two different dosages on thrombin generation in cancer patients.

  2010cites this paper
• Coagulation and cancer: Implications for diagnosis and management

  2010cites this paper
• Haemostatic Issues in Cancer Development and Progression: “The Role of Coagulation and Haemostatic Factors in cancer Development and Metastasis” Ph.D. Thesis

  2009cites this paper
• UvA-DARE ( Digital Academic Repository ) Heparins , cancer and thrombosis : clinical and experimental studies

  2009cites this paper
• General changes in hemostasis in gastric cancer.

  2009cites this paper
• FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer

  2009cites this paper
• THE COMPLEX EFFECTS OF HEPARINS ON CANCER PROGRESSION AND METASTASIS IN EXPERIMENTAL STUDIES

  2009cites this paper
• Cancer Metastasis and Immunotherapy Soluble Fibrin Inhibits Lymphocyte Adherence and Cytotoxicity Against Tumor Cells : Implications

  2008cites this paper
• Cerebrovascular Complications of Cancer

  2008cites this paper
• Soluble Fibrin Inhibits Lymphocyte Adherence and Cytotoxicity Against Tumor Cells: Implications for Cancer Metastasis and Immunotherapy

  2008cites this paper
• Characterization of the Pro-Thrombotic State in CAPD Patients

  2008cites this paper
• AVALIAÇÃO DO PERFIL OXIDATIVO E DA ATIVIDADE DE ECTOENZIMAS EM PACIENTES COM NEOPLASIA INTRA-EPITELIAL CERVICAL

  2008cites this paper
• Prognostic value of plasma D‐dimer levels in patients with colorectal cancer

  2008cites this paper
• Non-metastatic manifestations of cancer in the chest

  2008cites this paper
• Confusion after a game of bridge

  2007cites this paper
• To the Graduate Council:

  2007cites this paper
• Reactive thrombocytosis might contribute to chemotherapy-related thrombophilia in patients with lung cancer.

  2007cites this paper
• The Role of Soluble Fibrin in Lymphocyte and LAK Cell Adherence to and Migration across Vascular Endothelial Cells: Implications for Immunotherapy and Cancer

  2007cites this paper
• The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options

  2007cites this paper
• Risk of venous thrombosis in patients with pancreatic adenocarcinoma.

  2007cites this paper
• Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer.

  2006cites this paper
• Low-molecular-weight heparins in thrombosis and cancer: emerging links.

  2006cites this paper
• PROTEIN C, PROTEIN S AND ANTITHROMBIN III LEVELS IN BREAST CANCER

  2006cites this paper
• Effects of the chemotherapeutic agent doxorubicin on the protein C anticoagulant pathway

  2006cites this paper
• Soluble fibrin inhibits monocyte adherence and cytotoxicity against tumor cells: implications for cancer metastasis

  2006cites this paper
• Role of current and emerging antithrombotics in thrombosis and cancer.

  2006cites this paper
• Thrombosis in cancer patients

  2005cites this paper
• The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment

  2005cites this paper
• Coagulation et cancers bronchiques

  2005cites this paper
• Evaluation of thrombotic children with malignancy

  2005cites this paper
• Three-year evaluation of late breast reconstruction with a free transverse rectus abdominis musculocutaneous flap in a county hospital in Sweden: A retrospective study

  2005cites this paper
• Recurrent thromboembolism in ovarian cancer

  2004cites this paper
• Soluble CD40 Ligand Plasma Levels in Lung Cancer

  2004cites this paper
• Stroke in patients with cancer

  2004cites this paper
• [Recurrent ischemic strokes secondary to acquired hypercoagulability in a patient with prostatic adenocarcinoma].

  2004cites this paper
• Venous thromboembolism and malignancy

  2004cites this paper
• The heparins and cancer: review of clinical trials and biological properties

  2004cites this paper
• Recent Advances in the Epidemiology, Pathophysiology, and Management of Thrombosis in Cancer Patients

  2004cites this paper
• reviewof deep vein thrombosis: systematic estimation of clinical probability in the -dimer testing and D Combined use of rapid

  2004cites this paper
• Estrategia diagnóstica ante la sospecha de trombosis venosa profunda

  2004cites this paper
• Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review

  2004cites this paper
• The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces

  2003cites this paper
• Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers

  2003cites this paper
• Bleeding and thrombosis in the cancer patient

  2003cites this paper
• Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival.

  2003cites this paper
• Tissue Factor-Dependent Coagulation Activation and Impaired Fibrinolysis in Situ in Gastric Cancer

  2003cites this paper
• Thromboembolic complications of cancer: Epidemiology, pathogenesis, diagnosis, and treatment

  2003cites this paper
• Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer.

  2003cites this paper
• Plasma levels of D‐dimer in lung carcinoma

  2003influential citation
• Effects of Blood Contamination on Cerebrospinal Fluid Cell Counts, Protein, and D-dimer Concentrations

  2003cites this paper
• Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter

  2003cites this paper
• The clinical course of deep vein thrombosis in patients with gynecologic cancer.

  2002cites this paper
• Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer

  2002influential citation
• Alteration of haemostasis in non-metastatic gastric cancer.

  2001cites this paper
• Comparison of a Test for Soluble Fibrin Polymer (TpPTM) with a Standard Quantitative ELISA for D-dimer in Patients, without Current Thrombosis, who Have Cancer or Renal Disease

  2001cites this paper
• Cerebrovascular dysfunction in children with neoplastic disorders1

  2001cites this paper
• Hemostatic alterations in patients with benign and malignant colorectal disease during major abdominal surgery.

  2001cites this paper
• Acute abdomen during adjuvant chemotherapy: superior mesenteric artery thrombosis associated with CMF chemotherapy.

  2001cites this paper
• The immune system, apoptosis and apoptosis-related proteins in human ovarian tumors (a review).

  2001cites this paper
• Activation of coagulation and fibrinolysis during reconstructive microsurgery in patients with cancer

  2001cites this paper
• The Thrombophilic State in Cancer Patients

  2001cites this paper
• Prognostic significance of blood coagulation tests in lung cancer.

  2001cites this paper
• The complex effects of heparins on cancer progression and metastasis in experimental studies.

  2001cites this paper
• ACUTE ARTERIAL THROMBOSIS IN MICROSURGERY - CLINICAL AND EXPERIMENTAL STUDIES

  2001cites this paper
• Acquired thrombophilic syndromes.

  2001cites this paper
• Heparins, cancer and thrombosis: clinical and experimental studies

  2000cites this paper
• Latex-enhanced immunoturbidimetry allows D-dimer determination in plasma and serum samples.

  2000cites this paper
• Thrombosis in cancer patients.

  2000cites this paper
• Cancer, thrombosis, and anticoagulants

  2000cites this paper